Literature DB >> 8412791

Characterization of factor IX defects in hemophilia B patients.

A R Thompson1, S H Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8412791     DOI： 10.1016/0076-6879(93)22011-4

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  5 in total

1.  Haemophilia B: database of point mutations and short additions and deletions, fifth edition, 1994.

Authors:  F Giannelli; P M Green; S S Sommer; D P Lillicrap; M Ludwig; R Schwaab; P H Reitsma; M Goossens; A Yoshioka; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1994-09       Impact factor: 16.971

2.  The factor VIII C1 domain contributes to platelet binding.

Authors:  Ting-Chang Hsu; Kathleen P Pratt; Arthur R Thompson
Journal:  Blood       Date:  2007-10-04       Impact factor: 22.113

3.  Haemophilia B (sixth edition): a database of point mutations and short additions and deletions.

Authors:  F Giannelli; P M Green; S S Sommer; M C Poon; M Ludwig; R Schwaab; P H Reitsma; M Goossens; A Yoshioka; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1996-01-01       Impact factor: 16.971

4.  CRISPR/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse.

Authors:  Yuting Guan; Yanlin Ma; Qi Li; Zhenliang Sun; Lie Ma; Lijuan Wu; Liren Wang; Li Zeng; Yanjiao Shao; Yuting Chen; Ning Ma; Wenqing Lu; Kewen Hu; Honghui Han; Yanhong Yu; Yuanhua Huang; Mingyao Liu; Dali Li
Journal:  EMBO Mol Med       Date:  2016-05-02       Impact factor: 12.137

Review 5.  Nuclease-Mediated Gene Therapies for Inherited Metabolic Diseases of the Liver.

Authors:  Taylor E Bryson; Caitlin M Anglin; P Hudson Bridges; Renee N Cottle
Journal:  Yale J Biol Med       Date:  2017-12-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.